Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a …
A n D GUID eLIneS affordability may often dictate which medications may be prescribed.
Patients who have exhausted prescription drug coverage or who are uninsured may require …
Patients who have exhausted prescription drug coverage or who are uninsured may require …
Impact of OATP transporters on pharmacokinetics
A Kalliokoski, M Niemi - British journal of pharmacology, 2009 - Wiley Online Library
Membrane transporters are now recognized as important determinants of the
transmembrane passage of drugs. Organic anion transporting polypeptides (OATP) form a …
transmembrane passage of drugs. Organic anion transporting polypeptides (OATP) form a …
Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake
M Niemi, MK Pasanen, PJ Neuvonen, M Koulu - Pharmacological reviews, 2011 - Elsevier
The importance of membrane transporters for drug pharmacokinetics has been increasingly
recognized during the last decade. Organic anion transporting polypeptide 1B1 (OATP1B1) …
recognized during the last decade. Organic anion transporting polypeptide 1B1 (OATP1B1) …
Drug interactions with lipid‐lowering drugs: mechanisms and clinical relevance
PJ Neuvonen, M Niemi… - Clinical Pharmacology & …, 2006 - Wiley Online Library
Lipid‐lowering drugs, especially 3‐hydroxy‐3‐methylglutaryl–coenzyme A inhibitors
(statins), are widely used in the treatment and prevention of atherosclerotic disease. The …
(statins), are widely used in the treatment and prevention of atherosclerotic disease. The …
Role of cytochrome P450 2C8 in drug metabolism and interactions
Abstract During the last 10-15 years, cytochrome P450 (CYP) 2C8 has emerged as an
important drug-metabolizing enzyme. CYP2C8 is highly expressed in human liver and is …
important drug-metabolizing enzyme. CYP2C8 is highly expressed in human liver and is …
Inhibition and induction of human cytochrome P450 enzymes: current status
Variability of drug metabolism, especially that of the most important phase I enzymes or
cytochrome P450 (CYP) enzymes, is an important complicating factor in many areas of …
cytochrome P450 (CYP) enzymes, is an important complicating factor in many areas of …
Narrative review: statin-related myopathy
TR Joy, RA Hegele - Annals of internal medicine, 2009 - acpjournals.org
Statin-related myopathy is a clinically important cause of statin intolerance and
discontinuation. The spectrum of statin-related myopathy ranges from common but clinically …
discontinuation. The spectrum of statin-related myopathy ranges from common but clinically …
Statin-induced myopathy: a review and update
TT Abd, TA Jacobson - Expert opinion on drug safety, 2011 - Taylor & Francis
Introduction: Statin-induced myopathy is an important cause of statin intolerance and the
most common cause of statin discontinuation. Observational studies estimate that 10–15 …
most common cause of statin discontinuation. Observational studies estimate that 10–15 …
Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics
RH Ho, RG Tirona, BF Leake, H Glaeser, W Lee… - Gastroenterology, 2006 - Elsevier
Background & Aims The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase
inhibitors, or statins, target liver HMG-CoA and are of proven benefit in the prevention of …
inhibitors, or statins, target liver HMG-CoA and are of proven benefit in the prevention of …
Therapeutic roles of peroxisome proliferator–activated receptor agonists
B Staels, JC Fruchart - Diabetes, 2005 - Am Diabetes Assoc
Peroxisome proliferator–activated receptors (PPARs) play key roles in the regulation of
energy homeostasis and inflammation, and agonists of PPARα and-γ are currently used …
energy homeostasis and inflammation, and agonists of PPARα and-γ are currently used …